Simplify Logo

Full-Time

Financial Reporting Manager

Confirmed live in the last 24 hours

Shape Therapeutics

Shape Therapeutics

51-200 employees

Develops programmable RNA medicines using AI

AI & Machine Learning
Biotechnology

Compensation Overview

$110k - $166kAnnually

+ Annual Target Bonus + Sign-On Bonus + Equity Grant + Relocation Bonus

Senior

Seattle, WA, USA

Category
Financial Accounting
Accounting
Required Skills
NetSuite
Excel/Numbers/Sheets
Requirements
  • Bachelor's degree in Accounting or Finance; CPA certification required
  • 10+ years of professional experience in accounting and finance. Minimum 2 years of experience in technical accounting, financial reporting, and compliance
  • Thorough knowledge of US GAAP, SEC regulations, and other accounting standards (e.g., ASC 606, ASC 808, ASC 842, 409a valuations)
  • Must have participated in some capacity in internal control design and testing, including SOX compliance
  • Strong analytical and problem-solving skills
  • Excellent communication, presentation, and interpersonal skills
  • Strong ownership mentality and a continuous learning mindset
  • Proficiency in accounting software (NetSuite) and Microsoft Excel
Responsibilities
  • Assist in preparation of the Company’s annual financial statements and related schedules
  • Lead technical accounting research and drafting of memorandums on wide-ranging topics (revenue, leases, stock-based compensation, equity, debt, etc.)
  • Responsible for analysis and accounting of stock-based compensation, equity, and review of valuation reports
  • Maintain and update the accounting policies and procedures to ensure compliance with regulatory standards and industry best practices
  • Support the annual audit and interim review activities with the external auditors
  • Assist in the preparation of reports for the audit committee and management
  • Lead the design, implementation, and testing of internal controls over financial reporting, ensuring effectiveness and alignment with SOX requirements
  • Continuously monitor internal controls and collaborate cross-functionally to identify and address gaps and inefficiencies
  • Serve as a resource to the accounting team on technical accounting matters, providing guidance and training as needed to ensure accurate financial reporting and compliance
  • Support the FP&A team in the annual budget and ongoing forecasting processes

Shape Therapeutics specializes in programmable RNA medicine, using artificial intelligence to analyze data for developing new treatments. Their technology, RNAfix, modifies RNA instructions to correct genetic mutations without changing DNA, while smart-sensing vector designs allow for tailored gene expression in specific cell types. The company aims to create effective and safe medicines that address the root causes of diseases, distinguishing itself by combining AI with advanced RNA technology.

Company Stage

Series B

Total Funding

$147.5M

Headquarters

Seattle, Washington

Founded

2018

Growth & Insights
Headcount

6 month growth

1%

1 year growth

11%

2 year growth

28%
Simplify Jobs

Simplify's Take

What believers are saying

  • The appointment of industry veterans like David Epstein and Todd Simpson to the board signals strong leadership and strategic direction.
  • Collaborations with major pharmaceutical companies like Roche and Otsuka highlight ShapeTX's potential for impactful partnerships and market penetration.
  • Recognition as one of Fierce Biotech's 'Fierce 15' underscores the company's promise and innovation in the biotech sector.

What critics are saying

  • The complexity of integrating AI with RNA technology could lead to unforeseen technical challenges and delays.
  • The highly competitive biotech landscape means that ShapeTX must continuously innovate to maintain its edge.

What makes Shape Therapeutics unique

  • ShapeTX leverages AI to design novel RNA therapies, setting it apart from traditional biotech firms that may not integrate advanced computational methods.
  • Their RNAfix technology, which corrects RNA without altering DNA, offers a unique approach to treating genetic disorders, unlike many gene therapies that focus on DNA modification.
  • The company's smart-sensing vector designs enable precise gene expression tailored to specific cell types, providing a level of customization that is rare in the industry.

Help us improve and share your feedback! Did you find this helpful?